Surging Diabetes Market Lifts Dexcom Into Top Spot in S&P 500

(Bloomberg) -- Dexcom Inc.’s recent entry into the S&P 500 gave the benchmark a new leader for the year, dethroning stocks like Newmont Corp. and Regeneron Pharmaceuticals Inc. that have seen share...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.